| Name | Title | Contact Details |
|---|
Please select your location. United States International
Amring promotes health across communities by providing reliable, safe, and affordable medications bringing value to patients and improving quality of life.
Cytovia is dedicated to the development of transformational cancer immunotherapies, addressing several of the most challenging unmet medical needs including the prevention of cancer relapse and metastasis. Cytovia focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patient at the right stage of the disease. Cytovia has secured access to multiple advanced technologies, including allogeneic cell therapy, multispecific antibodies, and cytokines. Cytovia establishes development partnerships to accelerate time-to-market and commercialization alliances in order to optimize rapid adoption of its novel immunotherapies.
A Systematic Approach To Extractables And Leachables: A Review Of Guidance From The Industry